Literature DB >> 1997666

Demoralization and social supports among Holocaust survivors.

S Fenig1, I Levav.   

Abstract

This study attempted to investigate the opposing effects of degree of traumatization and of contemporary social supports on the demoralization scores of World War II survivors. The respondents were all married, Poland-born respondents living in socially contrasting neighborhoods in Tel Aviv, Israel. Two subgroups were defined, one that had been in Europe during World War II (index cases) and another that was in prestatehood Israel during the same period (comparison cases). All respondents were administered the Psychiatric Epidemiology Research Interview/Demoralization Scale, a short item scale investigating World War II experiences, and the Social Supports Network Inventory. Uni- and multivariate analyses were conducted using means and rates of demoralization as the dependent variable. The results show that demoralization scores were associated positively with dose effect (the more brutal the experience, the higher the scores) and inversely with social supports (the higher the acknowledged presence of contemporary supports, the lower the scores).

Entities:  

Mesh:

Year:  1991        PMID: 1997666     DOI: 10.1097/00005053-199103000-00010

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  3 in total

1.  Telephone vs face-to-face interviewing in a community psychiatric survey.

Authors:  S Fenig; I Levav; R Kohn; N Yelin
Journal:  Am J Public Health       Date:  1993-06       Impact factor: 9.308

2.  Expressions of Holocaust experience and their relationship to mental symptoms and physical morbidity among Holocaust survivor patients.

Authors:  Dov Shmotkin; Y Michael Barilan
Journal:  J Behav Med       Date:  2002-04

3.  Socio-demographic and clinical features associated with demoralization in medically ill in-patients.

Authors:  Carlo Marchesi; Carlo Maggini
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-07-11       Impact factor: 4.328

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.